Almost all cases of cervical cancer are caused by human papillomavirus (HPV). China
accounts for about a third of the global burden of cervical cancer, with about 98 900 new …

In May, 2013, a cluster of adverse events suspected to be linked to HPV vaccination were
reported in the Japanese media, prompting the Japanese Government to suspend proactive …

Vaccines have repeatedly proven successful in the fight against infectious diseases,
bringing some equity in health care to even the least developed regions of the world …

Cervical cancer is the second leading cause of death from cancer in women worldwide.
Since the introduction of Papanicolaou smear-based screening in the 1950s, mortality from …

Human papillomavirus (HPV) causes cervical cancer in half a million women each year, and
two genotypes, 16 and 18, account for about 70% of all cervical cancers worldwide. 1 Two …

With two powerful weapons—human papillomavirus (HPV) vaccine and screening—cervical
cancer has become an important preventable cancer success story. In May, 2018, the …

In a pair of articles in The Lancet Oncology, Lehtinen and colleagues1 and Wheeler and
colleagues2 present 4-year end-of-study data from a trial of a prophylactic human …

Globally, cervical cancer remains a public health issue of increasing concern that could be
addressed through the implementation of effective preventive measures such as human …

The discovery of human papillomavirus (HPV) DNA in cervical cancer by Harald zur Hausen
sparked 30 years of research that established that persistent cervical infection by certain …

The protective effects of human papillomavirus (HPV) vaccines against HPV-linked
precancerous lesions of the uterine cervix have been widely and incontrovertibly …